GlassScriptPhysician profile
Kenneth B Avery
NPI 1154334696
$789.15
in general payments reported to CMS, 2019-2025
10 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.54 · 2021: $49.33 · 2023: $233 · 2024: $317 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $664.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $478.90 | 2023-2025 | Nuzyra |
| Smith+Nephew, INC. | $135.20 | 2019-2024 | Collagenase Santyl |
| Convatec INC. | $50.35 | 2024-2025 | |
| Organogenesis INC. | $25.70 | 2024 | Apligraf |
| Integra Lifesciences Corporation | $21.83 | 2021 | |
| Globus Medical, INC. | $20.76 | 2025 | Senza |
| Mimedx Group, INC. | $18.24 | 2025 | |
| Bioventus LLC | $16.14 | 2024 | Exogen Ultrasound Bone Healing System |
| Urgo Medical North America, LLC | $15.68 | 2025 | Urgoclean Ag |
| Advanced Oxygen Therapy INC. | $6.35 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Avery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.